Patients who received appropriate treatment intensification ¶
Adjusted analyses, correcting for complexity of care level, age, HbA 1c, hypoglycemia, insulin use and hypertension, also showed that the obesity group more frequently failed in receiving pharmacological treatment intensification when required (odds ratio 1.87, 95% CI 1.02–3.45).Īssessment of albuminuria and/or creatinine * Moreover, in a sensitivity analysis considering the HbA 1c target of ≤7.0% (≤53 mmol/mol) for individuals younger than 65 years and without major comorbidities, 15.2% in the group without obesity and 25.0% in the group with obesity failed to receive intensification of treatment when indicated ( P = 0.01). When assessing the number of patients who received pharmacological treatment intensification when HbA 1c level was above the target, it was found that participants from the group without obesity more frequently received treatment intensification than those from the obesity group (67.4% vs. According to individualized glycemic targets, 43.4% of the participants without obesity and 46.6% with obesity presented with an HbA 1c level above the target ( P = 0.53). Both groups were similar regarding all quality indicators for diabetes care. 49.5%, P < 0.001) than patients with obesity. Patients without obesity were older (68.7 ± 9.0 vs.
Most baseline characteristics were similar among patients without obesity ( n = 198) and those with obesity ( n = 204) ( Table 1). According to the sample size calculation, 402 participants were included in this study.
0 kommentar(er)
